Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is attached herewith

290/LG/SE/SEP/2026/GBSL September 29, 2026 To To BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex, Dalal Street, Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code : 509079 Scrip Symbol : GUFICBIO Subject: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), and in continuation of our earlier intimation dated January 20, 2026, we are pleased to inform that the Company has received, on September 29, 2026, an appellate order dated September 28, 2026 under Section 250 of the Income Tax Act, 1961 (“the Act”), whereby the appeal filed by the Company against the income tax demand of Rs. 4,33,36,680/‐ (Rupees Four Crores Thirty Three Lakhs Thirty Six Thousand Six Hundred And Eighty Only) for the Assessment Year 2024‐25, arising pursuant to the computation under Section 143 of the Act on account of disallowance of expenditure, has been allowed in favour of the Company. The details required under Regulation 30 of the Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025‐CFD‐POD2/I/3762/2026 dated January 30, 2026 issued thereunder are as below: Particulars Details 1. Name of the Authority Commissioner of Income tax (Appeal) 2. Nature and details of the action(s) The appeal filed by the Company before the taken, initiated or order(s) passed Commissioner of Income Tax (Appeals) against the income tax demand of Rs. 4,33,36,680/‐, as per the computation under Section 143 of the Act on account of disallowance of expenditure for the Assessment Year 2024‐25, has been allowed in favour of the Company. 3. Date of receipt of direction or Order No. ITBA/APL/S/250/2026‐27/1093989837(1) order, including any ad‐interim or dated September 28, 2026 received by the Company interim orders, or any other on September 29, 2026 communication from the authority 4. Details of the violation(s) or Refer point 2 above contravention(s) committed or alleged to be committed. 5. Impact on financial, operation or The appellate order, upon being given effect to, shall other activities of the listed entity, result in deletion of the income tax demand of Rs. quantifiable in monetary terms to 4,33,36,680/‐ raised for Assessment Year 2024‐25. the extent possible. Kindly take the same on your record. Thanking You, Yours truly, For Gufic Biosciences Limited Ami Shah Company Secretary & Compliance Officer Membership No. A39579